Nrx Pharmaceuticals Inc (NRXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,430 | -28,622 | -28,982 | -23,092 | -5,512 |
| Depreciation Amortization | 165 | 143 | 43 | N/A | 1 |
| Accounts receivable | -48 | 48 | 12 | N/A | N/A |
| Other Working Capital | 331 | 1,409 | 51 | -516 | N/A |
| Other Operating Activity | -3,313 | 12,910 | 18,477 | 16,100 | 2,031 |
| Operating Cash Flow | $-4,295 | $-14,112 | $-10,399 | $-7,508 | $-3,480 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | N/A | -2,378 | -2,561 | N/A | N/A |
| Other Investing Activity | -213 | -432 | 0 | 0 | 0 |
| Investing Cash Flow | $-213 | $-2,810 | $-2,561 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 5,227 | 5,227 | 5,452 | 5,000 |
| Debt Repayment | N/A | -548 | -394 | -394 | -320 |
| Common Stock Issued | N/A | 9,468 | 9,468 | 3,255 | 3,255 |
| Other Financing Activity | 3,424 | 9,129 | 4,400 | 662 | -350 |
| Financing Cash Flow | $3,424 | $23,276 | $18,701 | $8,975 | $7,585 |
| Beginning Cash Position | 7,797 | 1,443 | 1,443 | 1,443 | 1,443 |
| End Cash Position | 6,713 | 7,797 | 7,184 | 2,910 | 5,548 |
| Net Cash Flow | $-1,084 | $6,354 | $5,741 | $1,467 | $4,105 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,295 | -14,112 | -10,399 | -7,508 | -3,480 |
| Free Cash Flow | -4,295 | -14,112 | -10,399 | -7,508 | -3,480 |